The African-PREDICT study is a longitudinal cohort study investigating the early development and progression of hypertension and cardiovascular disease in young, healthy adults. Approximately 1,200 Black and White adults aged 20 to 30 years were recruited and assessed between 2013 and 2017 from Potchefstroom and surrounding areas in the North West Province of South Africa. Participants were enrolled through community health workers, workplace outreach, and public advertisements, with efforts to include individuals from low, middle, and high socioeconomic backgrounds. The cohort is planned to be followed up every five years.
Study design
Cohort
Number of participants at first data collection
1,202 (participants)
Age at first data collection
20 - 30 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2013
Primary Institutions
North-West University (NWU)
University of New South Wales (UNSW)
Links
health-sciences.nwu.ac.za/hart/current-projects-african-predict
clinicaltrials.gov/show/NCT03292094
doi.org/10.1016/j.numecd.2020.12.021
Profile paper DOI
Funders
Boehringer Ingelheim
GlaxoSmithKline (GSK)
Medical Research Council (MRC)
Mediclinic Group
National Council on Science and Technology of Mexico (Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACyT)
Ongoing?
Yes
Data types collected
Engagement
Keywords